Kronos Bio, Inc. revenue breakdown overview

Kronos Bio, Inc. revenue for the last year amounted to 9.85 M USD, the most of which — 9.85 M USD — came from its highest performing source at the moment, Small Molecule Therapeutics, the year earlier bringing 6.29 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Kronos Bio, Inc. 9.85 M USD, and the year before that — 6.29 M USD.